Back to results
US 12,251,429 B2Granted
Methods and compositions for RNA-guided treatment of HIV infection
AssigneeTemple University of the Commonwealth System of Higher Education
InventorsKamel Khalili, Wenhui Hu, Yonggang Zhang
Life of this patent
Estimating the term…
Abstract
Compositions for specifically cleaving target sequences in retroviruses include nucleic acids encoding a Clustered Regularly Interspace Short Palindromic Repeat (CRISPR) associated endonuclease and a guide RNA sequence complementary to one or more target nucleic acid sequences in a retrovirus genome.
Claims1
A method of inactivating a viral deoxyribonucleic acid (DNA) sequence of a viral genome in a cell, the method comprising:
- (a) cutting the viral DNA sequence at a first target sequence using a CRISPR-Cas targeted to the first target sequence by a first guide ribonucleic acid (gRNA);
- (b) cutting the viral DNA sequence at a second target sequence using a CRISPR-Cas targeted to the second target sequence by a second gRNA, wherein the first target sequence and the second target sequence are different;
- and
- wherein the method results in inactivating 64% to 96% of the viral DNA sequence in the cell and excising the viral DNA sequence between the first target sequence and the second target sequence from the viral genome in the cell.
1 more element
Dependencies are inferred from the claim text.